Men's Health: Update on Prostate Cancer - 17th June 2021 - 12.30pm to 1.30pm
Prostate cancer now most commonly diagnosed cancer in
There were 49,029 diagnoses of prostate cancer in 2018,
meaning prostate cancer overtakes breast cancer as the most common cancer in
Too many men are diagnosed late
(approx 20% stage 4, no longer prostate confined, 17% at
latest NPCA report)
Stage 1 The tumour is contained in the prostate. The tumour
is too small to be felt on DRE or to be seen on a scan.
Stage 2 The tumour is still contained in the prostate, but
can be felt on DRE
Stage 3 The tumour has started to break through the outer
capsule of the prostate and may be in the seminal vesicles.
Stage 4 The tumour has spread outside the prostate. It may
have spread to areas such as the bladder or rectum. Or it may have spread
further, for example to the bones.
One-year net survival for prostate cancer is highest for
patients diagnosed at Stage 1, Stage 2, and lowest for those diagnosed at Stage
4, 100% of patients diagnosed at Stage 1 & Stage 2 survived their disease
for at least one year, compared to 88% of patients diagnosed at Stage 4.
Five-year net survival decreases from Stage 3 (96%) to Stage
4 (49%), a difference of 47 percentage points.
The presentation will focus on early diagnosis, advances in
treatment and dealing with complications at follow up
This course is being run as an online training course. Details of how to
join the meeting will be emailed to you closer to the event.